First-Trimester Plasmatic microRNAs Are Associated with Fasting Glucose Levels in Late Second Trimester of Pregnancy.

Autor: Légaré, Cécilia, Desgagné, Véronique, Thibeault, Kathrine, White, Frédérique, Clément, Andrée-Anne, Poirier, Cédrik, Luo, Zhong-Cheng, Scott, Michelle S., Jacques, Pierre-Étienne, Perron, Patrice, Guérin, Renée, Hivert, Marie-France, Bouchard, Luigi
Předmět:
Zdroj: Biomedicines; Jun2024, Vol. 12 Issue 6, p1285, 11p
Abstrakt: Maternal blood glucose regulation adaptation to pregnancy aims to support fetal growth but may also lead to the development of gestational diabetes mellitus, the most common pregnancy complication. MiRNAs are small RNA molecules secreted and stable in the blood, where they could have paracrine hormone-like functions (ribo-hormone) and regulate metabolic processes including fetal growth and glucose metabolism. The objective of this study was to identify plasmatic microRNA (miRNAs) measured during the first trimester of pregnancy that were associated with glucose levels during a 75 g oral glucose tolerance test (OGTT) at ~26 weeks of pregnancy. miRNAs were quantified using next-generation sequencing in 444 pregnant women and replicated in an independent cohort of 106 pregnant women. MiRNAs associated with glucose levels were identified with the DESeq2 package. We identified 24 miRNAs associated with fasting glycemia, of which 18 were common to both cohorts (q-value < 0.1). However, no association was found between miRNAs and 1 h or 2 h post OGTT glycemia. To conclude, we identified 18 miRNAs early in pregnancy that were associated with fasting blood glucose measured 3 months later. Our findings offer new insights into the mechanisms involved in fasting glucose homeostasis regulation in pregnancy, which is critical to understanding how gestational diabetes develops. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index